Newron Receives Fifth Tranche From Financing Agreement With European Investment Bank (Eib)
Round Type
Debt Financing
Description
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, announces that it has received Tranche 5 under its financing agreement with the European Investment Bank (EIB) that was signed in October 2018 and comprises up to EUR 40 million, subject to achieving a set of agreed performance criteria. The EIB loan is backed by the European Fund for Strategic Investments (EFSI), the central pillar of the Investment plan for Europe. Tranche 5 consists of EUR 7.5 million and will primarily be used to support the Company’s development programs in diseases of the central nervous system
Quick answer
Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised an undisclosed amount in a Debt Financing round, dated October 18, 2021. Newron Pharmaceuticals S.p.A. & EA Pharma Ltd is based in Milan, Lombardy, Italy.
- How much did Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raise?
- Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised an undisclosed amount in a Debt Financing round on October 18, 2021.
- What does Newron Pharmaceuticals S.p.A. & EA Pharma Ltd do?
- Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system.
- Where is Newron Pharmaceuticals S.p.A. & EA Pharma Ltd based and how big is it?
- Newron Pharmaceuticals S.p.A. & EA Pharma Ltd is based in Milan, Lombardy, Italy. Fundz records about 23 employees.
- Who are the decision-makers at Newron Pharmaceuticals S.p.A. & EA Pharma Ltd?
- Fundz holds 3 contacts at Newron Pharmaceuticals S.p.A. & EA Pharma Ltd, including the Chief Financial Officer, IAB Member. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Newron Pharmaceuticals S.p.A. & EA Pharma Ltd that raised within 45 days of this round, from Fundz verified event records.
- Acrivon Therapeutics raised $100M on November 23, 2021.
- Xencor raised $25M on November 19, 2021.
- Acrivon Therapeutics raised $100M (Series B) on November 11, 2021.
- MIRA Pharmaceuticals raised $6.5M on November 9, 2021.
- Structure Therapeutics raised $26M on October 21, 2021.
- Structure Therapeutics raised $32M on October 21, 2021.
Who to call at Newron Pharmaceuticals S.p.A. & EA Pharma Ltd, and when
A new round usually means Newron Pharmaceuticals S.p.A. & EA Pharma Ltd is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Newron Pharmaceuticals S.p.A. & EA Pharma Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Newron Pharmaceuticals S.p.A. & EA Pharma Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Newron Pharmaceuticals S.p.A. & EA Pharma Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.